Should methylene blue be the drug of choice to treat vasoplegias caused by cardiopulmonary bypass and anaphylactic shock?
- 1 March 2000
- journal article
- other
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 119 (3) , 632-633
- https://doi.org/10.1016/s0022-5223(00)70152-8
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Reversal of refractory hypotension with single-dose methylene blue after coronary artery bypass surgeryThe Journal of Thoracic and Cardiovascular Surgery, 1999
- Methylene Blue in Anaphylactic ShockAnnals of Emergency Medicine, 1997
- Endogenous nitric oxide and low systemic vascular resistance after cardiopulmonary bypassJournal of Cardiothoracic and Vascular Anesthesia, 1997
- Angiotensin-Converting Enzyme Inhibitors Increase Vasoconstrictor Requirements After Cardiopulmonary BypassAnesthesia & Analgesia, 1995